FBInvestor
Stocks / Stoke Therapeutics Inc
Institutional Ownership

Stoke Therapeutics Inc

CUSIP 86150R107COMSTOKQ1 2026

Institutional Holders
191
13F filers
Shares Held
67.87M
Aggregate institutional
Institutional Value
$2.13B
Q1 2026
Net New Holders
+12
38 new · 26 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions38
Increased79
Decreased52
Sold out26

Institutional Holders

191 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Rtw Investments, LP5.62M$183.10M+76.7KAdded
2Blackrock, Inc.5.39M$175.36M+173.2KAdded
3Fmr LLC5.38M$175.29M217.3KReduced
4Lynx1 Capital Management LP4.76M$155.11M641.0KReduced
5Redmile Group, LLC4.16M$135.58M+130.1KAdded
6Morgan Stanley3.42M$111.46M122.9KReduced
7Baker Bros. Advisors LP3.34M$108.64M0Held
8Toronto Dominion Bank3.17M$103.32M0Held
9Wellington Management Group LLP3.10M$100.80M+2.36MAdded
10Bvf Inc/Il2.55M$82.95M+281.9KAdded

181 more institutional holders on Premium

See every fund holding Stoke Therapeutics Inc, with full quarter-over-quarter share changes.

Unlock all holders